Polyethyleneimine and DNA nanoparticles-based gene therapy for acute lung injury.
about
Nanotechnology in respiratory medicineKallistatin protects against sepsis-related acute lung injury via inhibiting inflammation and apoptosis.Biological therapies in the acute respiratory distress syndrome.Maresin1 stimulates alveolar fluid clearance through the alveolar epithelial sodium channel Na,K-ATPase via the ALX/PI3K/Nedd4-2 pathway.Use of cilomilast-loaded phosphatiosomes to suppress neutrophilic inflammation for attenuating acute lung injury: the effect of nanovesicular surface charge.
P2860
Polyethyleneimine and DNA nanoparticles-based gene therapy for acute lung injury.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Polyethyleneimine and DNA nanoparticles-based gene therapy for acute lung injury.
@en
Polyethyleneimine and DNA nanoparticles-based gene therapy for acute lung injury.
@nl
type
label
Polyethyleneimine and DNA nanoparticles-based gene therapy for acute lung injury.
@en
Polyethyleneimine and DNA nanoparticles-based gene therapy for acute lung injury.
@nl
prefLabel
Polyethyleneimine and DNA nanoparticles-based gene therapy for acute lung injury.
@en
Polyethyleneimine and DNA nanoparticles-based gene therapy for acute lung injury.
@nl
P2093
P1476
Polyethyleneimine and DNA nanoparticles-based gene therapy for acute lung injury.
@en
P2093
Cheng-Wen Wu
Erh-Hsuan Lin
Hsiang-Yi Chang
Huei-Sin Hu
Kuang-Yao Yang
Shauh-Der Yeh
P304
P356
10.1016/J.NANO.2013.05.004
P577
2013-05-28T00:00:00Z